Phthalimide

Phthalimide

SCHEMBL220034

O=C1NC(=O)c2ccccc21.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.60
CASP3 P42574 4/20 0.57
CASP7 P55210 2/20 0.57
CASP6 P55212 2/20 0.57
CASP8 Q14790 2/20 0.57
CASP2 P42575 1/20 0.57
PARP1 P09874 2/20 0.41
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
PDGFRA P16234 1/20 0.41
FER P16591 1/20 0.41
LTK P29376 1/20 0.41
CDK8 P49336 1/20 0.41
ACVR1 Q04771 1/20 0.41
LRRK2 Q5S007 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
CES1 P23141 1/20 0.41
LMNA P02545 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalimide SCHEMBL31168291 1.00 GSK3B (0.60) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL27660070 0.86 GSK3B (0.62) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL3220884 0.85 GSK3B (0.68) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL29217853 0.85 GSK3B (0.75) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL27968411 0.85 GSK3B (0.75) GSK3BCASP3CASP7CASP6CASP8
Trifluoromethanesulfonic Acid SCHEMBL515455 0.84 PARP1 (0.67) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL3702796 0.83 GSK3B (0.48) GSK3BCASP3CASP7CASP6CASP8
Trifluoromethanesulfonic Acid SCHEMBL1026933 0.83 MAOA (0.47) GSK3BCASP3CASP7CASP6CASP8
Phthalimide SCHEMBL3700966 0.81 GSK3B (0.47) GSK3BCASP3CASP7CASP6CASP8
Trifluoromethanesulfonic Acid SCHEMBL27913668 0.81 MAOA (0.46) GSK3BCASP3CASP7CASP6CASP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566036-B2 Comprising polyhydroxystyrene protected by 1-ethoxyethanol, photosensitive acid generator, solvent and polystyrene filler; dimensional and shape control of semiconductors; responsive to design rule of <0.15mu m; miniaturization NEC ELECTRONICS CORPORATION (JP) 2003-05-20 US claimed
CN-1093645-C Photoresist material and method for producing semiconductor constituted of corrosion resist picture thereof NEC CORP (JP) 2002-10-30 CN claimed
US-20010009749-A1 Chemically amplified resist NEC CORPORATION 2001-07-26 US claimed
US-6096478-A Resist material for forming a chemically amplified negative type resist pattern and method of manufacturing a semiconductor device employing the resist pattern NEC CORPORATION (JP) 2000-08-01 US claimed
CN-1227355-A Photoresist material and method for producing semiconductor constituted of corrosion resist picture thereof NEC CORP (JP) 1999-09-01 CN claimed
US-5498765-A Positive photoresist composition containing photoacid generator and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1996-03-12 US claimed
US-5374500-A Positive photoresist composition containing photoacid generator and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1994-12-20 US claimed
EP-0619522-A2 Positive photoresist composition containing photoacid generator and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1994-10-12 EP claimed
WO-2026097702-A1 PHOTOSENSITIVE COMPOSITION, METHOD FOR PREPARING PATTERN, CURED PRODUCT, AND ELECTRONIC COMPONENT 江苏艾森半导体材料股份有限公司 2026-05-15 WO disclosed
US-20240427245-A1 PHOTOSENSITIVE RESIN AND PHOTORESIST COMPOSITION CONTAINING THE SAME TAKOMA TECHNOLOGY CO., LTD. (KR) 2024-12-26 US disclosed
CN-118786388-A Photosensitive resin and photoresist composition comprising the same 塔科马科技有限公司 2024-10-15 CN disclosed
WO-2024122681-A1 PHOTOSENSITIVE RESIN AND PHOTORESIST COMPOSITION COMPRISING SAME 타코마테크놀러스 주식회사 2024-06-13 WO disclosed
CN-118103774-A Photosensitive resin composition, photosensitive resin coating, photosensitive dry film, and pattern forming method 信越化学工业株式会社 2024-05-28 CN disclosed
CN-113527101-B Novel compound, polymer, process for producing the same, photosensitive resin composition, pattern forming process, cured film, and electronic component 信越化学工业株式会社 2024-04-23 CN disclosed
CN-1227355-A Photoresist material and method for producing semiconductor constituted of corrosion resist picture thereof NEC CORP (JP) 1999-09-01 CN disclosed
EP-0718644-A2 Production process of color filter CANON KABUSHIKI KAISHA (JP) 1996-06-26 EP disclosed
US-5498765-A Positive photoresist composition containing photoacid generator and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1996-03-12 US disclosed
US-5374500-A Positive photoresist composition containing photoacid generator and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1994-12-20 US disclosed
EP-0619522-A2 Positive photoresist composition containing photoacid generator and use thereof INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1994-10-12 EP disclosed
US-5272042-A Positive photoresist system for near-UV to visible imaging INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1993-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240427245-A1 PHOTOSENSITIVE RESIN AND PHOTORESIST COMPOSITION CONTAINING THE SAME LCP1, TERB1, EED GSK3B 4786/4885CASP3 3048/4885CASP7 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.